Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma

By Banzai Chiaki   Nishino Koji   Quan Jinhua   Yoshihara Kosuke   Sekine Masayuki   Yahata Tetsuro   Tanaka Kenichi  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 127-132

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation

By Groenendijk Floris   Taal Walter   Dubbink Hendrikus   Haarloo Cathleen   Kouwenhoven Mathilde   Bent Martin   Kros Johan   Dinjens Winand  

Journal of Neuro-Oncology, Vol. 101, Iss. 3, 2011-02 ,pp. : 405-417

Springer Publishing Company

Access to resources Recommend Favorite

Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients

By Balañá Carmen  

Clinical and Translational Oncology, Vol. 13, Iss. 9, 2011-09 ,pp. : 677-685

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation in malignant gliomas

By Riemenschneider Markus  

Targeted Oncology, Vol. 5, Iss. 3, 2010-09 ,pp. : 161-165

Springer Publishing Company

Access to resources Recommend Favorite

Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer

By Takahashi Yusuke   Iwaya Takeshi   Sawada Genta   Kurashige Junji   Matsumura Tae   Uchi Ryutaro   Ueo Hiroki   Takano Yuki   Eguchi Hidetoshi   Sudo Tomoya   Sugimachi Keishi   Yamamoto Hirofumi   Doki Yuichiro   Mori Masaki   Mimori Koshi  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 205-212

Springer Publishing Company

Access to resources Recommend Favorite